Fidelity International’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-481,200
Closed -$7.13M 992
2020
Q3
$7.13M Sell
481,200
-950,835
-66% -$14.1M 0.01% 514
2020
Q2
$21.1M Sell
1,432,035
-1,039,208
-42% -$15.3M 0.03% 382
2020
Q1
$29M Buy
2,471,243
+296,078
+14% +$3.48M 0.05% 303
2019
Q4
$51.1M Buy
2,175,165
+377,940
+21% +$8.88M 0.07% 255
2019
Q3
$33.2M Buy
1,797,225
+283,590
+19% +$5.25M 0.05% 301
2019
Q2
$28.1M Sell
1,513,635
-272,673
-15% -$5.07M 0.04% 326
2019
Q1
$43.7M Sell
1,786,308
-481,546
-21% -$11.8M 0.07% 253
2018
Q4
$58.8M Sell
2,267,854
-795,529
-26% -$20.6M 0.1% 206
2018
Q3
$97M Buy
3,063,383
+103,224
+3% +$3.27M 0.14% 170
2018
Q2
$115M Buy
+2,960,159
New +$115M 0.17% 151